Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
Methods of preventing secondary infections
US10610588B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10610588-B2 |
| Application number | US-201615549161-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 9, 2016 |
| Priority date | Feb 9, 2015 |
| Publication date | Apr 7, 2020 |
| Grant date | Apr 7, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A method of treating or preventing a disease associated with a secondary infection in a subject infected with a pathogen is provided. The method comprises administering to the subject a therapeutically effective amount of an anti-pathogenic agent directed towards the pathogen and a therapeutically effective amount of an agent which down-regulates at least one extracellular matrix-associated polypeptide.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating a subject infected with a pathogen comprising administering to the subject a therapeutically effective amount of an anti-pathogenic agent directed towards said pathogen and a therapeutically effective amount of an agent which specifically down-regulates membrane type 1-matrix metalloproteinase 1 (MT1-MMP1), thereby treating the subject. 2. A method of treating influenza in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an agent which specifically down-regulates MT1-MMP1. 3. The method of claim 2 , wherein the administering is effected no more than 2 days after the start of symptoms of the infection. 4. The method of claim 1 , wherein said agent which specifically down-regulates MT1-MMP1 is an antibody.
Assignees
Inventors
Classifications
against enzymes · CPC title
- A61K39/3955Primary
against proteinaceous materials, e.g. enzymes, hormones, lymphokines · CPC title
not condensed with another ring · CPC title
Drugs for disorders of the respiratory system · CPC title
comprising antibodies · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10610588B2 cover?
- A method of treating or preventing a disease associated with a secondary infection in a subject infected with a pathogen is provided. The method comprises administering to the subject a therapeutically effective amount of an anti-pathogenic agent directed towards the pathogen and a therapeutically effective amount of an agent which down-regulates at least one extracellular matrix-associated pol…
- Who is the assignee on this patent?
- Yeda Res & Dev
- What technology area does this patent fall under?
- Primary CPC classification A61K39/3955. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).